Alyeska Investment Group
ASND icon

Alyeska Investment Group’s Ascendis Pharma A/S ASND Stock Holding History

Alyeska Investment Group’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-42,416
Closed -$6.61M – 561
2025
Q1 		$6.61M Sell
42,416
-112,584
-73% -$16.1M 0.03% 346
2024
Q4 		$21.3M Buy
155,000
+40,000
+35% +$5.26M 0.08% 250
2024
Q3 		$17.2M Buy
115,000
+55,000
+92% +$7.43M 0.09% 248
2024
Q2 		$8.18M Buy
+60,000
New +$8.16M 0.05% 292
2023
Q4 		– Sell
-112,994
Closed -$10.6M – 522
2023
Q3 		$10.6M Buy
112,994
+67,994
+151% +$6.36M 0.07% 272
2023
Q2 		$4.02M Hold
45,000
– – 0.03% 353
2023
Q1 		$4.82M Buy
+45,000
New +$5.15M 0.04% 302
2019
Q3 		– Sell
-39,101
Closed -$4.5M – 407
2019
Q2 		$4.5M Sell
39,101
-16,777
-30% -$2.01M 0.06% 248
2019
Q1 		$6.58M Buy
+55,878
New +$4.89M 0.09% 203
2018
Q4 		– Sell
-9,000
Closed -$638K – 364
2018
Q3 		$638K Sell
9,000
-28,190
-76% -$1.94M 0.01% 368
2018
Q2 		$2.47M Buy
37,190
+10,490
+39% +$690K 0.02% 334
2018
Q1 		$1.75M Sell
26,700
-59,800
-69% -$3.36M 0.01% 358
2017
Q4 		$3.46M Sell
86,500
-23,500
-21% -$854K 0.03% 283
2017
Q3 		$3.99M Buy
+110,000
New +$3.16M 0.03% 309
2015
Q4 		– Sell
-67,079
Closed -$1.19M – 377
2015
Q3 		$1.19M Buy
67,079
+6,139
+10% +$120K 0.01% 376
2015
Q2 		$1.08M Sell
60,940
-39,015
-39% -$683K 0.01% 402
2015
Q1 		$1.73M Buy
+99,955
New +$1.82M 0.02% 383

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alyeska Investment Group's ASND Position: Q2 2025 in Review

Alyeska Investment Group sold out of Ascendis Pharma A/S (ASND) in Q2 2025, closing a stake of 42,416 shares — an estimated $6.61M sold.

Alyeska Investment Group first reported a position in ASND in Q1 2015 and held it in 17 quarters. The position peaked at $21.3M in Q4 2024. 247 funds tracked by Wall St. Rank hold ASND as of Q2 2025.

  • Alyeska Investment Group reported no remaining Ascendis Pharma A/S position as of Q2 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 42,416 Ascendis Pharma A/S shares in Q2 2025, an estimated $6.61M.
  • Alyeska Investment Group first reported a position in Ascendis Pharma A/S in Q1 2015 and held it in 17 quarters.
  • Alyeska Investment Group's Ascendis Pharma A/S position peaked at $21.3M in Q4 2024.
  • 247 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2025.

Based on Alyeska Investment Group's 13F filing for Q2 2025, filed 14 Aug 2025.